Bernard Lammek

[1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin

Marian Kruszynski, Bernard Lammek, Maurice Manning et al. · Journal of Medicinal Chemistry · 1980 · 448 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin

Maurice Manning, Marian Kruszynski, Krzysztof Bańkowski et al. · Journal of Medicinal Chemistry · 1989 · 106 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Synthetic antagonists of in vivo antidiuretic and vasopressor responses to arginine-vasopressin

Maurice Manning, Bernard Lammek, Alexander M. Kolodziejczyk et al. · Journal of Medicinal Chemistry · 1981 · 75 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Raman and surface‐enhanced Raman spectroscopy investigation of vasopressin analogues containing 1‐aminocyclohexane‐1‐carboxylic acid residue

Edyta Podstawka, Emilia Sikorska, Leonard M. Proniewicz et al. · Biopolymers · 2006 · 51 citations · Full text

Natural Sciences, Biochemistry, Chemistry +17

The Multi-Leu Peptide Inhibitor Discriminates Between PACE4 and Furin And Exhibits Antiproliferative Effects On Prostate Cancer Cells

Christine Levesque, Martin Fugère, Anna Kwiatkowska et al. · Journal of Medicinal Chemistry · 2012 · 49 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16